The assay utilizes a specific antibody to 25(OH D for coating magnetic particles (solid phase) and a vitamin D analog, 22-carboxy-23,24,25,26,27-pentanorvitamin D3, linked to an isoluminol derivative.
We performed the shRNA technique to down-regulate nuclear localized Kaiso, and we utilized a specific Kaiso antibody as a control.
We therefore compared three methods of Treg depletion and/or elimination, utilizing low dose cyclophosphamide (CY), a specific antibody directed against the IL-2 receptor found on Tregs (PC61) and the use of denileukin diftitox (DD), which is a fusion protein designed to have a direct cytocidal action on cells which express the IL-2 receptor.
For each reaction, 5 μg of a specific antibody or the control serum were utilized.
Based on target specificity, assay dynamic range, and effects of EGF stimulation, the optimal antibody pairing for measurement of activated HER1-HER2 heterodimers utilized a HER2-specific antibody together with a HER1 antibody specific for the kinase domain phosphotyrosine 1173 to produce a pHER1-HER2 assay.
The second method utilized a conformation-specific antibody, Alz-50 [ 22], which recognized NFTs and dystrophic neurites in AD-affected brains [ 30, 31].
More recently, RDTs have been developed to distinguish P. vivax parasitaemia by utilizing a pLDH antibody specific to P. vivax.
Consistent with this, a more recent report utilized an MeCP2E1-specific antibody to demonstrate that the E1 protein is also widely expressed, with its highest expression in the cortex and cerebellum, and it is also expressed in high amounts in neurons as compared to astrocytes [ 54].
Our study extends the group of patients in whom this phenomenon has been described to four additional patients, and in addition to histopathologic analysis, we performed immunofluorescent staining of this tissue utilizing a cytokeratin 3 specific antibody.
Utilizing a neutralizing antibody, we demonstrate that B7-H1 negatively regulates TMEV-specific ex vivo production of interferon (IFN -γ, IFN -γeukinterleukin IL -17 and IL -17rom CD4+ and CD8+ T cells.
